Phage Therapy of Mycobacterium Infections: Compassionate-use of Phages in Twenty Patients with Drug-Resistant Mycobacterial Disease.
Rebekah M DedrickBailey E SmithMadison CristinzianoKrista G FreemanDeborah Jacobs-SeraYvonne BelessisA Whitney BrownKeira A CohenRebecca M DavidsonDavid van DuinAndrew GaineyCristina Berastegui GarciaC R Robert GeorgeGhady HaidarWinnie IpJonathan IredellAmeneh KhatamiJessica S LittleKirsi MalmivaaraBrendan J McMullanDavid E MichalikAndrea MoscatelliJerry A NickMaria G Tupayachi OrtizHari M PolenakovikPaul D RobinsonMikael SkurnikDaniel A SolomonJames SoothillHelen SpencerPeter WarkAusten WorthRobert T SchooleyConstance A BensonGraham F HatfullPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Phage treatment of Mycobacterium infections is challenging due to the limited repertoire of therapeutically useful phages, but favorable clinical outcomes in patients lacking any other treatment options support continued development of adjunctive phage therapy for some mycobacterial infections.